Trial of Decitabine in Patients With Acute Myeloid Leukemia

Clinical trial NCT00260832 · COMPLETED

Trial details

NCT number: NCT00260832
Sponsor: Eisai Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2005-11-01
Primary completion: 2009-10-01
Enrollment: 485

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.